1. Home
  2. RLMD vs HMR Comparison

RLMD vs HMR Comparison

Compare RLMD & HMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RLMD
  • HMR
  • Stock Information
  • Founded
  • RLMD 2004
  • HMR 1984
  • Country
  • RLMD United States
  • HMR Greece
  • Employees
  • RLMD N/A
  • HMR N/A
  • Industry
  • RLMD Biotechnology: Pharmaceutical Preparations
  • HMR Marine Transportation
  • Sector
  • RLMD Health Care
  • HMR Consumer Discretionary
  • Exchange
  • RLMD Nasdaq
  • HMR Nasdaq
  • Market Cap
  • RLMD 66.7M
  • HMR 77.4M
  • IPO Year
  • RLMD N/A
  • HMR N/A
  • Fundamental
  • Price
  • RLMD $1.99
  • HMR $1.24
  • Analyst Decision
  • RLMD Hold
  • HMR Strong Buy
  • Analyst Count
  • RLMD 2
  • HMR 2
  • Target Price
  • RLMD $1.00
  • HMR $6.00
  • AVG Volume (30 Days)
  • RLMD 517.7K
  • HMR 143.6K
  • Earning Date
  • RLMD 11-06-2025
  • HMR 11-11-2025
  • Dividend Yield
  • RLMD N/A
  • HMR N/A
  • EPS Growth
  • RLMD N/A
  • HMR N/A
  • EPS
  • RLMD N/A
  • HMR N/A
  • Revenue
  • RLMD N/A
  • HMR $27,657,887.00
  • Revenue This Year
  • RLMD N/A
  • HMR $36.04
  • Revenue Next Year
  • RLMD N/A
  • HMR $35.83
  • P/E Ratio
  • RLMD N/A
  • HMR N/A
  • Revenue Growth
  • RLMD N/A
  • HMR N/A
  • 52 Week Low
  • RLMD $0.24
  • HMR $1.09
  • 52 Week High
  • RLMD $3.98
  • HMR $10.04
  • Technical
  • Relative Strength Index (RSI)
  • RLMD 59.73
  • HMR N/A
  • Support Level
  • RLMD $1.89
  • HMR N/A
  • Resistance Level
  • RLMD $2.84
  • HMR N/A
  • Average True Range (ATR)
  • RLMD 0.28
  • HMR 0.00
  • MACD
  • RLMD 0.01
  • HMR 0.00
  • Stochastic Oscillator
  • RLMD 37.96
  • HMR 0.00

About RLMD Relmada Therapeutics Inc.

Relmada Therapeutics Inc is a clinical-stage biotechnology company. It is engaged in developing chemical entities with novel versions of drug products that address areas of high unmet medical need in the treatment of central nervous system diseases. The company is focused on the development of esmethadone (d-methadone, dextromethadone, REL-1017), an N-methyl-D-aspartate (NMDA) receptor antagonist. Its key product candidate, esmethadone, is an oral agent for the treatment of depression and other potential indications.

About HMR Heidmar Maritime Holdings Corp. Common Stock

Heidmar Maritime Holdings Corp is an asset-light tanker pool, and commercial and technical management company. The company is a fast-growing tanker pool company engaged in the commercial management and chartering of crude oil and refined petroleum product tankers. The company has also recently expanded its business to offer pool management of dry bulk vessels and technical management. The company generates maximum revenue from Singapore.

Share on Social Networks: